Closed DSuveges closed 1 month ago
@DSuveges close?
This issue is not yet ready to be closed. The two schemas are still divergent, but it is not so important at the moment jump on it.
To be honest, I am not 100%sure how to properly model biomarkers.
Background
@JarrodBaker drew my attention to the fact that there’s a discrepancy on how
biomarkers
are represented in different evidence sets. In the cancer_biomarkers there arebiomarkerName
andbiomarkers
, which is not a list, but an object in which there are two properties:variant
(array) and ageneExpression
(array). In the new evidence set prepared for the partner preview,biomarkers
is a list with objects with propertiesname
anddescription
. This discrepancy needs resolved.On the partner preview front-end biomarkers are shown as chips, where the descriptions are shown upon hover-over. In case of cancer_biomarker evidence is displayed on a more detailed way.
Tasks
Acceptance tests